Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632641 · ClinicalTrials.gov registry record · NA
Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT04632641 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 107 participants.
The verdict
NCT04632641, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
Primary objective: To compare the safety and efficacy of closure strategies post venous access procedures. Hypothesis: We anticipate that the use of a venous closure device will decrease the time to hemostasis (TTH), time to ambulation (TTA) and time to discharge (TTD) compared to conventional methods of closure following venous access procedure.
Interventions
- DEVICE Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES
- OTHER Figure 8 Suture - LARGE-BORE PROCEDURES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2021-04-23 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04632641
The ClinicalTrials.gov registry entry for NCT04632641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES is the first listed.
NCT04632641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04632641 about?
NCT04632641 is a clinical study titled "Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial". Primary objective: To compare the safety and efficacy of closure strategies post venous access procedures. Hypothesis: We anticipate that the use of a venous closure device will decrease the time to hemostasis (TTH), time to ambulation (TTA) and time to discharge (TTD) compared to conventional meth...
What is the current status of trial NCT04632641?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2021-04-23. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04632641?
The interventions under investigation include: Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES (DEVICE), Figure 8 Suture - LARGE-BORE PROCEDURES (OTHER).
Who is sponsoring clinical trial NCT04632641?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.